Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2-(1,3-dicyclohexyl-6-hydroxy-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamido)acetic Acid
2. Gsk1278863
1. 960539-70-2
2. Gsk1278863
3. Gsk-1278863
4. N-((1,3-dicyclohexylhexahydro-2,4,6-trioxopyrimidin-5-yl)carbonyl)glycine
5. Gsk 1278863
6. Jvr38zm64b
7. 2-[(1,3-dicyclohexyl-2,4,6-trioxo-1,3-diazinan-5-yl)formamido]acetic Acid
8. Glycine, N-((1,3-dicyclohexylhexahydro-2,4,6-trioxo-5-pyrimidinyl)carbonyl)-
9. Duvroq
10. (1,3-dicyclohexyl-2,4,6-trioxohexahydropyrimidine-5-carbonyl)glycine
11. 2-[(1,3-dicyclohexyl-2,4,6-trioxo-1,3-diazinane-5-carbonyl)amino]acetic Acid
12. Daprodustat [usan:inn]
13. Unii-jvr38zm64b
14. Duvroq (tn)
15. Daprodustat [inn]
16. Daprodustat [jan]
17. Daprodustat [usan]
18. Daprodustat [who-dd]
19. Daprodustat; Gsk1278863
20. Daprodustat (jan/usan/inn)
21. Gtpl8455
22. Daprodustat (gsk1278863)
23. Chembl3544988
24. Schembl21725048
25. Dtxsid501337360
26. Amy27907
27. Bcp16766
28. Ex-a1121
29. Mfcd29924726
30. S8171
31. Akos027439964
32. Zinc231226004
33. Ccg-268574
34. Cs-5453
35. Db11682
36. Sb19761
37. Ac-30915
38. Bg166670
39. Hy-17608
40. Db-096637
41. J3.560.573h
42. D10874
43. A902761
44. Q27076986
45. Daprodustat;(1,3-dicyclohexyl-2,4,6-trioxohexahydropyrimidine-5-carbonyl)glycine
| Molecular Weight | 393.4 g/mol |
|---|---|
| Molecular Formula | C19H27N3O6 |
| XLogP3 | 2.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 5 |
| Exact Mass | 393.18998559 g/mol |
| Monoisotopic Mass | 393.18998559 g/mol |
| Topological Polar Surface Area | 124 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 627 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of anaemia due to chronic disorders
B - Blood and blood forming organs
B03 - Antianemic preparations
B03X - Other antianemic preparations
B03XA - Other antianemic preparations
B03XA07 - Daprodustat
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
Annual Reports
Main Therapeutic Indication : Hematology
Currency : USD
2020 Revenue in Millions : 6
2019 Revenue in Millions : 0
Growth (%) : New Launch
Main Therapeutic Indication : Hematology
Currency : USD
2021 Revenue in Millions : 22
2020 Revenue in Millions : 6
Growth (%) : 333
Main Therapeutic Indication : Hematology
Currency : USD
2022 Revenue in Millions : 50
2021 Revenue in Millions : 22
Growth (%) : 127
Main Therapeutic Indication : Hematology
Currency : USD
2023 Revenue in Millions : 67
2022 Revenue in Millions : 50
Growth (%) : 50
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
Market Place
